NCT00818805View on ClinicalTrials.gov

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2008

Conditions

Allergic Conjunctivitis

Interventions

DRUG

Olopatadine 0.1%

one drop in one eye

DRUG

Tranilast 0.5%

one drop in one eye

DRUG

Placebo (Olopatadine)

one drop in contralateral eye

DRUG

Placebo (Tranilast)

one drop in contralateral eye

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY